$175.60
0.790.45%
At Close: -
$175.48
-0.12-0.07%
After Hours: 1:13 PM EDT
15 minutes delayed
Zoetis
ZTSNYSE
Zoetis (NYSE:ZTS) Stock, Analyst Ratings, Price Targets, Predictions
Zoetis Inc has a consensus price target of $202.75, established from looking at the 47 latest analyst ratings. The last 3 analyst ratings were released from HSBC, Goldman Sachs, and Stifel on May 8, 2024, May 6, 2024, and April 30, 2024. With an average price target of $200.33 between HSBC, Goldman Sachs, and Stifel, there's an implied 14.16% upside for Zoetis Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HSBC
Goldman Sachs
Stifel
Barclays
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Zoetis
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | Buy Now | 28.22% | HSBC | Morten Herholdt | $230 → $225 | Maintains | Buy | Get Alert |
| 05/06/2024 | Buy Now | 11.69% | Goldman Sachs | Nathan Rich | $223 → $196 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 2.58% | Stifel | Jonathan Block | $195 → $180 | Maintains | Buy | Get Alert |
| 04/23/2024 | Buy Now | 31.07% | Barclays | Balaji Prasad | $260 → $230 | Maintains | Overweight | Get Alert |
| 04/16/2024 | Buy Now | 11.12% | Piper Sandler | David Westenberg | $220 → $195 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | 11.12% | Stifel | Jonathan Block | $215 → $195 | Maintains | Buy | Get Alert |
| 02/20/2024 | Buy Now | 25.37% | Piper Sandler | David Westenberg | $215 → $220 | Maintains | Overweight | Get Alert |
| 02/14/2024 | Buy Now | 48.17% | Barclays | Balaji Prasad | $255 → $260 | Maintains | Overweight | Get Alert |
| 01/17/2024 | Buy Now | 28.79% | Goldman Sachs | Nathan Rich | $190 → $226 | Maintains | Buy | Get Alert |
| 12/19/2023 | Buy Now | 31.07% | Jefferies | Glen Santangelo | → $230 | Assumes | → Buy | Get Alert |
| 11/06/2023 | Buy Now | 22.52% | Piper Sandler | David Westenberg | $210 → $215 | Maintains | Overweight | Get Alert |
| 10/30/2023 | Buy Now | 11.12% | Stifel | Jonathan Block | $205 → $195 | Maintains | Buy | Get Alert |
| 09/12/2023 | Buy Now | 16.82% | Stifel | Jonathan Block | → $205 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2023 | Buy Now | 31.07% | HSBC | Morten Herholdt | → $230 | Initiates | → Buy | Get Alert |
| 08/28/2023 | Buy Now | 16.82% | Stifel | Jonathan Block | $195 → $205 | Maintains | Buy | Get Alert |
| 08/14/2023 | Buy Now | 25.37% | Piper Sandler | David Westenberg | $210 → $220 | Maintains | Overweight | Get Alert |
| 08/10/2023 | Buy Now | 21.38% | Goldman Sachs | Nathan Rich | $204 → $213 | Maintains | Buy | Get Alert |
| 06/14/2023 | Buy Now | 28.22% | Atlantic Equities | Steve Chesney | → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 05/26/2023 | Buy Now | 28.22% | Atlantic Equities | Steve Chesney | → $225 | Reiterates | Overweight → Overweight | Get Alert |
| 05/08/2023 | Buy Now | 19.67% | Piper Sandler | David Westenberg | $220 → $210 | Maintains | Overweight | Get Alert |
| 02/21/2023 | Buy Now | 48.17% | Barclays | Balaji Prasad | $250 → $260 | Maintains | Overweight | Get Alert |
| 11/15/2022 | Buy Now | 41.33% | Morgan Stanley | Erin Wright | $264 → $248 | Maintains | Overweight | Get Alert |
| 11/04/2022 | Buy Now | 2.58% | B of A Securities | Michael Ryskin | $225 → $180 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | 2.58% | Goldman Sachs | Nathan Rich | $207 → $180 | Maintains | Buy | Get Alert |
| 10/17/2022 | Buy Now | 28.22% | JP Morgan | Chris Schott | $250 → $225 | Maintains | Overweight | Get Alert |
| 07/21/2022 | Buy Now | 15.11% | Goldman Sachs | Nathan Rich | $208 → $202 | Maintains | Buy | Get Alert |
| 07/12/2022 | Buy Now | 16.82% | Piper Sandler | David Westenberg | → $205 | Initiates | → Overweight | Get Alert |
| 06/29/2022 | Buy Now | 28.22% | Stifel | Jonathan Block | $225 → $225 | Maintains | Buy | Get Alert |
| 06/24/2022 | Buy Now | 28.22% | Stifel | Jonathan Block | $275 → $225 | Maintains | Buy | Get Alert |
| 06/17/2022 | Buy Now | 13.97% | Argus Research | Jasper Hellweg | $225 → $200 | Maintains | Buy | Get Alert |
| 05/19/2022 | Buy Now | 18.53% | Goldman Sachs | Nathan Rich | $237 → $208 | Maintains | Buy | Get Alert |
| 03/09/2022 | Buy Now | 18.53% | Citigroup | Navaan Ty | $232 → $208 | Maintains | Neutral | Get Alert |
| 02/16/2022 | Buy Now | 44.75% | B of A Securities | Michael Ryskin | $258 → $254 | Maintains | Buy | Get Alert |
| 01/10/2022 | Buy Now | 39.62% | Barclays | Balaji Prasad | $240 → $245 | Maintains | Overweight | Get Alert |
| 01/07/2022 | Buy Now | 56.71% | Stifel | Jonathan Block | $250 → $275 | Maintains | Buy | Get Alert |
| 12/20/2021 | Buy Now | 32.21% | Citigroup | Navann Ty | — | Maintains | Neutral | Get Alert |
| 11/18/2021 | Buy Now | 50.44% | Morgan Stanley | Erin Wright | — | Initiates | → Overweight | Get Alert |
| 11/09/2021 | Buy Now | 39.62% | Goldman Sachs | Nathan Rich | $220 → $245 | Maintains | Buy | Get Alert |
| 11/05/2021 | Buy Now | 36.77% | Barclays | — | — | Maintains | Overweight | Get Alert |
| 10/27/2021 | Buy Now | 28.22% | B of A Securities | Michael Ryskin | $225 → $225 | Maintains | Buy | Get Alert |
| 10/26/2021 | Buy Now | 31.07% | Stifel | Jonathan Block | $220 → $230 | Maintains | Buy | Get Alert |
| 08/09/2021 | Buy Now | 31.07% | Credit Suisse | Katie Tryhane | — | Maintains | Outperform | Get Alert |
| 08/06/2021 | Buy Now | 33.92% | Barclays | Balaji Prasad | — | Maintains | Overweight | Get Alert |
| 08/05/2021 | Buy Now | 25.37% | Stifel | Jonathan Block | $185 → $220 | Maintains | Buy | Get Alert |
| 08/04/2021 | Buy Now | 17.39% | Credit Suisse | Katie Tryhane | → $206 | Assumes | Outperform → Outperform | Get Alert |
| 07/27/2021 | Buy Now | 28.22% | B of A Securities | Michael Ryskin | → $225 | Maintains | Buy | Get Alert |
| 07/16/2021 | Buy Now | — | Raymond James | Elliot Wilbur | — | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Zoetis (ZTS) stock?
The latest price target for Zoetis (NYSE:ZTS) was reported by HSBC on May 8, 2024. The analyst firm set a price target for $225.00 expecting ZTS to rise to within 12 months (a possible 28.22% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zoetis (ZTS)?
The latest analyst rating for Zoetis (NYSE:ZTS) was provided by HSBC, and Zoetis maintained their buy rating.
When was the last upgrade for Zoetis (ZTS)?
There is no last upgrade for Zoetis
When was the last downgrade for Zoetis (ZTS)?
The last downgrade for Zoetis Inc happened on July 16, 2021 when Raymond James changed their price target from N/A to N/A for Zoetis Inc.
When is the next analyst rating going to be posted or updated for Zoetis (ZTS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zoetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zoetis was filed on May 8, 2024 so you should expect the next rating to be made available sometime around May 8, 2025.
Is the Analyst Rating Zoetis (ZTS) correct?
While ratings are subjective and will change, the latest Zoetis (ZTS) rating was a maintained with a price target of $230.00 to $225.00. The current price Zoetis (ZTS) is trading at is $175.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.